• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide.全球危重症儿童中心静脉导管通畅的持续低剂量肝素输注相关因素
Pediatr Crit Care Med. 2016 Aug;17(8):e352-61. doi: 10.1097/PCC.0000000000000854.
2
Rates of Venous Thromboembolism and Central Line-Associated Bloodstream Infections Among Types of Central Venous Access Devices in Critically Ill Children.危重症儿童不同类型中心静脉通路装置的静脉血栓栓塞症和中心静脉导管相关血流感染发生率
Crit Care Med. 2020 Sep;48(9):1340-1348. doi: 10.1097/CCM.0000000000004461.
3
A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.肝素与安慰剂输注延长新生儿外周放置经皮中心静脉导管(PCVC)使用时间的随机对照试验:HIP(PCVC肝素输注)研究
Pediatrics. 2007 Jan;119(1):e284-91. doi: 10.1542/peds.2006-0529.
4
Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.低分子量肝素预防儿童中心静脉导管相关血栓形成
Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD005982. doi: 10.1002/14651858.CD005982.pub3.
5
Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.持续输注肝素以预防经外周置入经皮中心静脉导管的新生儿发生血栓形成和导管堵塞。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD002772. doi: 10.1002/14651858.CD002772.pub2.
6
Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.持续输注肝素以预防外周置入经皮中心静脉导管的新生儿发生血栓形成和导管堵塞。
Cochrane Database Syst Rev. 2001(3):CD002772. doi: 10.1002/14651858.CD002772.
7
Heparin-bonded catheters for prolonging the patency of central venous catheters in children.用于延长儿童中心静脉导管通畅时间的肝素涂层导管
Cochrane Database Syst Rev. 2014 Feb 25;2014(2):CD005983. doi: 10.1002/14651858.CD005983.pub3.
8
Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.持续输注肝素以预防经外周置入经皮中心静脉导管的新生儿发生血栓形成和导管堵塞。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD002772. doi: 10.1002/14651858.CD002772.pub3.
9
Age-Dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children: A Post Hoc Analysis of a Bayesian Phase 2b Randomized Clinical Trial.年龄依赖性异质性:依诺肝素预防危重症儿童导管相关性血栓形成的疗效:贝叶斯 2b 期随机临床试验的事后分析。
Crit Care Med. 2021 Apr 1;49(4):e369-e380. doi: 10.1097/CCM.0000000000004848.
10
Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD005983. doi: 10.1002/14651858.CD005983.pub2.

引用本文的文献

1
Room utilization analysis of pre-operative glue embolization for venous malformations: procedure times and outcomes.静脉畸形术前胶水栓塞的手术室使用情况分析:手术时间及结果
Pediatr Radiol. 2025 May 28. doi: 10.1007/s00247-025-06270-x.
2
Invasive Mechanical Ventilation and Risk of Hospital-Acquired Venous Thromboembolism.有创机械通气与医院获得性静脉血栓栓塞风险。
Respir Care. 2024 Oct 25;69(11):1392-1399. doi: 10.4187/respcare.11698.
3
Hospital-Acquired Venous Thromboembolism and Invasive Mechanical Ventilation: A Report From the Children's Hospital Acquired Thrombosis Consortium.医院获得性静脉血栓栓塞症和有创机械通气:来自儿童获得性血栓形成联盟的报告。
Pediatr Crit Care Med. 2024 Feb 1;25(2):e82-e90. doi: 10.1097/PCC.0000000000003383. Epub 2023 Oct 26.

本文引用的文献

1
Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.肝素与0.9%氯化钠间断冲管预防成人中心静脉导管堵塞的比较
Cochrane Database Syst Rev. 2014 Oct 8(10):CD008462. doi: 10.1002/14651858.CD008462.pub2.
2
A multinational study of thromboprophylaxis practice in critically ill children.一项关于危重症儿童抗血栓预防治疗实践的多国研究。
Crit Care Med. 2014 May;42(5):1232-40. doi: 10.1097/CCM.0000000000000147.
3
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.新生儿和儿童的抗血栓治疗:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
4
A multicenter survey of heparin prophylaxis practice in pediatric critical care.一项关于儿科重症监护中肝素预防措施应用情况的多中心调查。
J Intensive Care Med. 2011 Sep-Oct;26(5):314-7. doi: 10.1177/0885066610392501. Epub 2011 Mar 24.
5
Survey of pharmacologic thromboprophylaxis in critically ill children.危重症儿童的药物性血栓预防调查。
Crit Care Med. 2011 Jul;39(7):1773-8. doi: 10.1097/CCM.0b013e3182186ec0.
6
A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial.肝素在全胃肠外营养中预防新生儿长导管相关性败血症的随机对照试验:肝素在长导管全胃肠外营养(HILLTOP)试验。
Arch Dis Child Fetal Neonatal Ed. 2010 Jul;95(4):F252-7. doi: 10.1136/adc.2009.167403. Epub 2010 Jun 7.
7
The effect of low-dose heparin on maintaining peripherally inserted percutaneous central venous catheters in neonates.低剂量肝素对维持新生儿外周置入中心静脉导管的作用。
J Perinatol. 2010 Dec;30(12):794-9. doi: 10.1038/jp.2010.46. Epub 2010 Apr 8.
8
Thrombosis in the critically ill neonate: incidence, diagnosis, and management.危重新生儿的血栓形成:发病率、诊断与管理
Vasc Health Risk Manag. 2008;4(6):1337-48. doi: 10.2147/vhrm.s4274.
9
Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.癌症患儿中心静脉导管两种不同冲洗方式的前瞻性随机试验。
J Clin Oncol. 2009 Apr 20;27(12):2059-65. doi: 10.1200/JCO.2008.19.4860. Epub 2009 Mar 9.
10
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).新生儿及儿童抗栓治疗:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):887S-968S. doi: 10.1378/chest.08-0762.

全球危重症儿童中心静脉导管通畅的持续低剂量肝素输注相关因素

Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide.

作者信息

Onyeama Sara-Jane N, Hanson Sheila J, Dasgupta Mahua, Hoffmann Raymond G, Faustino Edward Vincent S

机构信息

1Medical College of Wisconsin, Milwaukee, WI. 2Department of Pediatrics, Medical College of Wisconsin, WI. 3Critical Care Division, Children's Hospital of Wisconsin, Milwaukee, WI. 4Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI. 5Department of Pediatrics, Yale School of Medicine, New Haven, CT.

出版信息

Pediatr Crit Care Med. 2016 Aug;17(8):e352-61. doi: 10.1097/PCC.0000000000000854.

DOI:10.1097/PCC.0000000000000854
PMID:27362853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4980163/
Abstract

OBJECTIVES

To identify patient, hospital, and central venous catheter factors that may influence the use of low-dose heparin infusion for central venous catheter patency in critically ill children.

DESIGN

Secondary analysis of an international multicenter observational study.

SETTING

Fifty-nine PICUs over four study dates in 2012, involving seven countries.

PATIENTS

Children less than 18 years old with a central venous catheter who were admitted to a participating unit and enrolled in the completed Prophylaxis against Thrombosis Practice study were included. All overflow patients were excluded.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Of the 2,484 patients in the Prophylaxis against Thrombosis Practice study, 1,312 patients had a central venous catheter. Five hundred seven of those patients used low-dose heparin infusion. The frequency of low-dose heparin infusion was compared across various patient, hospital, and central venous catheter factors using chi-square, Mann-Whitney U, and Fisher exact tests. In the multivariate analysis, age was not a significant factor for low-dose heparin infusion use. Patients with pulmonary hypertension had decreased low-dose heparin infusion use, whereas those with active surgical or trauma diagnoses had increased low-dose heparin infusion use. All centrally inserted central venous catheters were more likely to use low-dose heparin infusion when compared with peripherally inserted central venous catheters. The Asia-Pacific region showed increased low-dose heparin infusion use, along with community hospitals and smaller ICUs (< 10 beds).

CONCLUSIONS

Patient, central venous catheter, and hospital factors are associated with the use of low-dose heparin infusion in critically ill children. Further study is needed to evaluate the efficacy and persistence of low-dose heparin infusion use.

摘要

目的

确定可能影响在危重症儿童中使用低剂量肝素输注以保持中心静脉导管通畅的患者、医院及中心静脉导管相关因素。

设计

一项国际多中心观察性研究的二次分析。

地点

2012年四个研究日期间的59个儿科重症监护病房,涉及7个国家。

患者

纳入入住参与研究单位且参加已完成的预防血栓形成实践研究的18岁以下中心静脉置管儿童。排除所有溢出患者。

干预措施

无。

测量指标及主要结果

在预防血栓形成实践研究的2484例患者中,1312例患者有中心静脉导管。其中507例患者使用低剂量肝素输注。使用卡方检验、曼-惠特尼U检验和费舍尔精确检验,比较了不同患者、医院及中心静脉导管因素下低剂量肝素输注的频率。在多变量分析中,年龄不是低剂量肝素输注使用的显著因素。患有肺动脉高压的患者低剂量肝素输注使用率降低,而有外科手术或创伤诊断的患者低剂量肝素输注使用率增加。与外周置入中心静脉导管相比,所有中心置入的中心静脉导管更有可能使用低剂量肝素输注。亚太地区、社区医院和较小的重症监护病房(<10张床位)低剂量肝素输注使用率增加。

结论

患者、中心静脉导管及医院因素与危重症儿童低剂量肝素输注的使用相关。需要进一步研究以评估低剂量肝素输注使用的疗效和持续性。